Patent details

Basic Information

Publication number:

EP3411062

PCT Application Number:

US2017016120

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177481116

PCT Publication Number:

WO2017136492

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF CD24 PROTEINS FOR TREATING LEPTIN-DEFICIENT CONDITIONS

French Title of Invention:

UTILISATION DE PROTÉINES CD24 POUR TRAITER DES PATHOLOGIES À DÉFICIENCE EN LEPTINE

German Title of Invention:

VERWENDUNG VON CD24-PROTEINEN ZUR BEHANDLUNG VON LEPTIN-DEFIZIENTEN ERKRANKUNGEN

SPC Number:

Dates

Filing date:

02/02/2017

Grant date:

25/11/2020

EP Publication Date:

12/12/2018

PCT Publication Date:

10/08/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/11/2020

EP B1 Publication Date:

25/11/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/02/2021

Expiration date:

02/02/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/11/2020

 

 

Name:

Oncoimmune Inc.

Address:

9430 Key West Avenue Suite 113, Rockville, Maryland 20850, United States (US)

Inventor

1

Name:

LIU, Yang

Address:

United States (US)

2

Name:

ZHENG, Pan

Address:

United States (US)

3

Name:

DEVENPORT, Martin

Address:

United States (US)

Priority

Priority Number:

201662290202 P

Priority Date:

02/02/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/17; A61K 38/22; A61P 5/00; C07K 14/195; C07K 14/44; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

202048

Publication date:

25/11/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages